loadpatents
Patent applications and USPTO patent grants for Gale; Jonathan B..The latest application filed is for "antibody-sn-38 immunoconjugates with a cl2a linker".
Patent | Date |
---|---|
Antibody-SN-38 immunoconjugates with a CL2A linker Grant 10,751,420 - Govindan , et al. A | 2020-08-25 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker App 20190030175 - Govindan; Serengulam V. ;   et al. | 2019-01-31 |
Antibody-SN-38 immunoconjugates with a CL2A linker Grant 10,143,756 - Govindan , et al. De | 2018-12-04 |
Antibody-SN-38 immunoconjugates with a CL2A linker Grant 10,034,950 - Govindan , et al. July 31, 2 | 2018-07-31 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker App 20180161440 - Govindan; Serengulam V. ;   et al. | 2018-06-14 |
Antibody-SN-38 immunoconjugates with a CL2A linker Grant 9,931,417 - Govindan , et al. April 3, 2 | 2018-04-03 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker App 20180085469 - Govindan; Serengulam V. ;   et al. | 2018-03-29 |
Antibody-SN-38 immunoconjugates with a CL2A linker Grant 9,855,344 - Govindan , et al. January 2, 2 | 2018-01-02 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker App 20170165370 - Govindan; Serengulam V. ;   et al. | 2017-06-15 |
Antibody-SN-38 immunoconjugates with a CL2A linker Grant 9,629,926 - Govindan , et al. April 25, 2 | 2017-04-25 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker App 20160303253 - Govindan; Serengulam V. ;   et al. | 2016-10-20 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker App 20160256562 - Govindan; Serengulam V. ;   et al. | 2016-09-08 |
Antibody-SN-38 immunoconjugates with a CL2A linker Grant 9,375,489 - Govindan , et al. June 28, 2 | 2016-06-28 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker App 20150306243 - Govindan; Serengulam V. ;   et al. | 2015-10-29 |
Antibody-SN-38 immunoconjugates with a CL2A linker Grant 9,107,960 - Govindan , et al. August 18, 2 | 2015-08-18 |
Antibody-sn-38 Immunoconjugates With A Cl2a Linker App 20140227180 - Govindan; Serengulam V. ;   et al. | 2014-08-14 |
Heteroarotinoids as anticancer agents Grant 4,833,254 - Berlin , et al. May 23, 1 | 1989-05-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.